Dr. Beroukhim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
450 Brookline Ave
Boston, MA 02215Phone+1 617-632-2166- Is this information wrong?
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2002 - 2006
University of California (San Francisco)Residency, Internal Medicine, 2000 - 2003- University of California San Francisco School of MedicineClass of 2000
Certifications & Licensure
MA State Medical License 2002 - 2025
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Publications & Presentations
PubMed
- Author Correction: An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κB.Min, J., Zaslavsky, A., Fedele, G., McLaughlin, S., Reczek, E., De Raedt, T., Guney, I., Strochlic, D., MacConaill, L., Bronson, R., Ryeom, S., Hahn, W., Cichowski, K....> ;Nature Medicine. 2024 Feb 21
- Aberrant DNA repair reveals a vulnerability in histone H3.3-mutant brain tumors.Giulia Giacomini, Sandra Piquet, Odile Chevallier, Juliette Dabin, Siau-Kun Bai, Byungjin Kim, Robert Siddaway, Brian Raught, Etienne Coyaud, Chun-Min Shan, Robert J D...> ;Nucleic Acids Research. 2024 Mar 21
- Genomic sequence context differs between germline and somatic structural variants allowing for their differentiation in tumor samples without paired normals.Chukwu, W., Lee, S., Crane, A., Zhang, S., Mittra, I., Dubois, F., Dalin, S., Imielinski, M., Beroukhim, R.> ;Biorxiv. 2023 Dec 4
- Join now to see all
Journal Articles
- PIK3CA Amplification Associates with Aggressive Phenotype but Not Markers of AKT-MTOR Signaling in Endometrial CarcinomaRameen Beroukhim, William J Gibson, Clinical Cancer Research
- Author Correction: Targeting Wild-Type KRAS-Amplified Gastroesophageal Cancer Through Combined MEK and SHP2 InhibitionDaniel Catenacci, Adam J Bass, Shaunt Fereshetian, Rameen Beroukhim, Nature
- Genetic and Transcriptional Evolution Alters Cancer Cell Line Drug ResponseTodd R Golub, Rameen Beroukhim, Pratiti Bandopadhayay, Nature
- Join now to see all
Press Mentions
Everything ChangesMay 27th, 2020- Study Eyes Partially Lost Essential Genes as Possible Targets in CancerMay 25th, 2020
Ancestry Link to Cancer Molecular MakeupMay 12th, 2020- Join now to see all
Hospital Affiliations
Dana-Farber Cancer InstituteBoston, Massachusetts
Brigham and Women's HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
